Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement.
about
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgeryThe risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapyManagement of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillationLong-term anticoagulation. Indications and management.Assessment of pericardium in cardiac bioprostheses. A review.Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation.Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans.Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.Intracerebral haemorrhages and oral anticoagulation in the north of Scotland.Oral anticoagulation and risk of death: a medical record linkage study.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinicAcute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatmentAcute gastrointestinal haemorrhage in patients treated with anticoagulant drugs.Atrial fibrillation: epidemiology and the risk and prevention of stroke.Thromboembolism and prosthetic heart valves.Dental management considerations for the patient with an acquired coagulopathy. Part 2: Coagulopathies from drugs.Non-rheumatic atrial fibrillation: warfarin or aspirin for all?Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Effect of age on international normalized ratio at the time of major bleeding in patients treated with warfarin.Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?Evolution of left atrial thrombus with anticoagulant therapy-follow-up by transesophageal echocardiography.Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders.Antithrombotic therapy following bioprosthetic aortic valve replacement.Challenges in managing anticoagulant therapy in patients with heart valve prostheses.Manual and automated prothrombin time tests.Should we anticoagulate after bioprosthetic aortic valve replacement?Long-term use of oral anticoagulants. Current recommendations.New strategies for effective treatment of vitamin K antagonist-associated bleeding.Stroke prophylaxis: hypertension management and antithrombotic therapy.Safer anticoagulant therapy after heart valve replacement. Recommendations for less intense regimens.Anticoagulation--'sufficient conclusions from insufficient premises'?Monitoring sodium warfarin therapy using the international normalized ratioThe use of oral anticoagulants (warfarin) in older people. American Geriatrics Society guideline.When bleeding complicates oral anticoagulant therapy.[Antiplatelet or anticoagulative strategies after surgical/interventional valve treatment].Spontaneous and non-spontaneous bleeding complications in patients with oral vitamin K antagonist therapy.International Normalized Ratios (INR): the first 20 years.
P2860
Q24187077-90227A29-D3A4-453C-AF89-9483ABCF05EAQ24808679-2D893770-5EC6-4618-9AE0-038D8F421D14Q28167261-49AE32D8-4442-46C1-BB90-5786C48D5DA9Q33617257-63D482BB-2413-4797-A513-95A7E154F040Q33642641-691D1601-5606-46DC-99E0-A35A9654A9B3Q33843461-93F67F2A-402C-4C34-A8E7-D40106D9C0EBQ33978811-D2F8B502-5795-4383-8909-F8EFB5B87BB0Q34053704-76F59F7F-7DB3-4078-AC30-B27F9E4BCFBBQ34075223-A9473286-E0B6-4F59-B293-2189AE05061AQ34210279-FC7B0134-E3B0-4A97-93DB-07805F923600Q34252907-2C1088DD-2CA6-4226-80F5-F6A433B566BCQ34371473-70F711AC-F8A6-4A9E-B5AE-33447185BCFAQ34378863-A4BDDE33-E393-403B-BC85-DE97F3CFA1A3Q34407756-C74D2637-EC04-4106-A1F8-0D3AAF50F770Q35341637-1BB4A8A4-9369-4CAB-B4D5-6927311445B9Q35550021-D1D04E7F-E8AA-42CE-A12E-29C076AD2D03Q35581058-F224567C-41D2-4AEC-B556-BCDB09CB54A3Q35605975-3C9F60D0-0267-4CC3-972D-162319BCAA6BQ35752576-29683435-EBD2-4A3C-ACCD-8DC9A80C1FB7Q35752584-16129D05-37A3-42EE-8AB5-1C127B820547Q35783707-5BB1261F-1644-4858-8173-ABDC70829555Q35826999-D30EDAB4-E9EB-4851-AAB7-F144A49E9555Q35938916-87903BCC-F6D0-48C6-9851-CF8A971C6AC5Q36652525-C6A2133F-866F-44AF-96C9-3646E8F2C2BBQ36724271-B42D67C4-9844-4874-BA46-118A26749780Q36815991-D63D12E8-2FE3-47FC-AA94-F27D190A7473Q37247838-1AF4E7E7-558F-4C6A-A3BD-5CC168732649Q38161522-D0703C7C-7D0B-4218-8171-F1215B977E86Q38235695-5513E023-BA63-492A-966F-A41CDA30A10DQ38543287-E3064AE4-9591-4B7D-B42D-F9F1216F5DFCQ40898602-AB8CEEBF-8378-44DC-B683-CFBDC61F804FQ41387481-71E6C298-0B3F-49B7-8807-2D3C0F206D1AQ41873395-72A6C680-D2A7-49EC-B8B0-9AFAABA91546Q42580533-76989D7F-6239-42FC-8EEC-BB2395764EF7Q44091776-2C5F19B8-8AB0-4961-A718-F6FE621659D1Q49908797-7B6D58A8-CC9E-4DDF-8CFA-5C17878A473FQ49935648-0710F2A6-6A84-416E-9465-49AE50BF518FQ51136199-B1BD0CA9-B44B-401A-A7F3-5C17F81F5A6EQ53289581-F6EBB165-C0EF-4CD5-B120-B60A87E81CF3
P2860
Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Randomised comparison of two i ...... issue heart valve replacement.
@en
Randomised comparison of two i ...... issue heart valve replacement.
@nl
type
label
Randomised comparison of two i ...... issue heart valve replacement.
@en
Randomised comparison of two i ...... issue heart valve replacement.
@nl
prefLabel
Randomised comparison of two i ...... issue heart valve replacement.
@en
Randomised comparison of two i ...... issue heart valve replacement.
@nl
P2093
P1433
P1476
Randomised comparison of two i ...... issue heart valve replacement.
@en
P2093
P304
P356
10.1016/S0140-6736(88)92070-3
P407
P577
1988-06-01T00:00:00Z